CLINICAL_TRIALS
trial_result
· 2023-02-09
Clinical Trial Update: A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus [Phase 3]
Summary
A Phase 3 study of ORMD-0801 in type 2 diabetes mellitus was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oramed, Ltd. | Conditions: T2DM (Type 2 Diabetes Mellitus) | Phase 3 | Status: TERMINATED